Literature DB >> 18266271

An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection.

Cindy Allenbach1, Pascal Launois, Christoph Mueller, Fabienne Tacchini-Cottier.   

Abstract

TNF is an essential player in infections with Leishmania major, contributing to the control of the inflammatory lesion and, to a lesser degree, to parasite killing. However, the relative contribution of the soluble and transmembrane forms of TNF in these processes is unknown. To investigate the role of transmembrane TNF (mTNF) in the control of L. major infections, mTNF-knock-in (mTNF(Delta/Delta)) mice, which express functional mTNF but do not release soluble TNF, were infected with L. major, and the development of the inflammatory lesion and the immune response was compared to that occurring in L. major-infected TNF(-/-) and wild-type mice. mTNF(Delta/Delta) mice controlled the infection and resolved their inflammatory lesion as well as wild-type mice, a process associated with the early clearance of neutrophils at the site of parasite infection. In contrast, L. major-infected TNF(-/-) mice developed non-healing lesions, characterized by an elevated presence of neutrophils at the site of infection and partial control of parasite number within the lesions. Altogether, the results presented here demonstrate that mTNF, in absence of soluble TNF, is sufficient to control infection due to L. major, enabling the regulation of inflammation, and the optimal killing of Leishmania parasites at the site of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266271     DOI: 10.1002/eji.200737662

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

2.  Let off the leash: kala-azar following the use of tumour necrosis factor antibodies.

Authors:  Anjum Khan; Gerald Coakley; Catherine Cosgrove; Diana Lockwood
Journal:  BMJ Case Rep       Date:  2010-10-13

3.  Transmembrane tumor necrosis factor alpha is required for enteropathy and is sufficient to promote parasite expulsion in gastrointestinal helminth infection.

Authors:  M X Ierna; H E Scales; C Mueller; C E Lawrence
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  Differential Interactions of Serum and Bronchoalveolar Lavage Fluid Complement Proteins with Conidia of Airborne Fungal Pathogen Aspergillus fumigatus.

Authors:  Sarah Sze Wah Wong; Irene Daniel; Jean-Pierre Gangneux; Jeya Maheshwari Jayapal; Hélène Guegan; Sarah Dellière; Prajna Lalitha; Rajashri Shende; Taruna Madan; Jagadeesh Bayry; J Iñaki Guijarro; Dharmalingam Kuppamuthu; Vishukumar Aimanianda
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

5.  TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection.

Authors:  Ma Junaliah Tuazon Kels; Esther Ng; Zahrah Al Rumaih; Pratikshya Pandey; Sigrid R Ruuls; Heinrich Korner; Timothy P Newsome; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

6.  Cutaneous and visceral leishmaniasis during anti-TNFα therapy.

Authors:  Claudio Guarneri; Valentina Bevelacqua; James W Patterson; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2016-11-10

Review 7.  Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Authors:  Takahiko Horiuchi; Hiroki Mitoma; Shin-ichi Harashima; Hiroshi Tsukamoto; Terufumi Shimoda
Journal:  Rheumatology (Oxford)       Date:  2010-03-01       Impact factor: 7.580

8.  TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection.

Authors:  Ulrike Schleicher; Katrin Paduch; Andrea Debus; Stephanie Obermeyer; Till König; Jessica C Kling; Eliana Ribechini; Diana Dudziak; Dimitrios Mougiakakos; Peter J Murray; Renato Ostuni; Heinrich Körner; Christian Bogdan
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

9.  Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis.

Authors:  Deivid Costa Soares; Teresa C Calegari-Silva; Ulisses G Lopes; Valéria L Teixeira; Izabel C N de Palmer Paixão; Claudio Cirne-Santos; Dumith Chequer Bou-Habib; Elvira M Saraiva
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

Review 10.  The prominent role of neutrophils during the initial phase of infection by Leishmania parasites.

Authors:  Mélanie Charmoy; Floriane Auderset; Cindy Allenbach; Fabienne Tacchini-Cottier
Journal:  J Biomed Biotechnol       Date:  2009-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.